These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
153 related items for PubMed ID: 24039899
1. Relationship between the use of inhaled steroids for chronic respiratory diseases and early outcomes in community-acquired pneumonia. Almirall J, Bolíbar I, Serra-Prat M, Palomera E, Roig J, Hospital I, Carandell E, Agustí M, Ayuso P, Estela A, Torres A, Community-Acquired Pneumonia in Catalan Countries (PACAP). PLoS One; 2013; 8(9):e73271. PubMed ID: 24039899 [Abstract] [Full Text] [Related]
9. Cost-effectiveness of roflumilast as an add-on to triple inhaled therapy vs triple inhaled therapy in patients with severe and very severe COPD associated with chronic bronchitis in the UK. Kiff C, Ruiz S, Varol N, Gibson D, Davies A, Purkayastha D. Int J Chron Obstruct Pulmon Dis; 2018 Aug; 13():2707-2720. PubMed ID: 30214188 [Abstract] [Full Text] [Related]
10. Increased risk of community-acquired pneumonia in COPD patients with comorbid cardiovascular disease. Lin SH, Perng DW, Chen CP, Chai WH, Yeh CS, Kor CT, Cheng SL, Chen JJ, Lin CH. Int J Chron Obstruct Pulmon Dis; 2016 Aug; 11():3051-3058. PubMed ID: 27980402 [Abstract] [Full Text] [Related]
11. Seasonality, risk factors and burden of community-acquired pneumonia in COPD patients: a population database study using linked health care records. Williams NP, Coombs NA, Johnson MJ, Josephs LK, Rigge LA, Staples KJ, Thomas M, Wilkinson TM. Int J Chron Obstruct Pulmon Dis; 2017 Aug; 12():313-322. PubMed ID: 28176888 [Abstract] [Full Text] [Related]
13. Prognostic factors in hospitalized community-acquired pneumonia: a retrospective study of a prospective observational cohort. Ito A, Ishida T, Tokumasu H, Washio Y, Yamazaki A, Ito Y, Tachibana H. BMC Pulm Med; 2017 May 02; 17(1):78. PubMed ID: 28464807 [Abstract] [Full Text] [Related]
14. Prehospital use of inhaled corticosteroids and point prevalence of pneumonia at the time of hospital admission: secondary analysis of a multicenter cohort study. Festic E, Bansal V, Gajic O, Lee AS, United States Critical Illness and Injury Trials Group: Lung Injury Prevention Study Investigators (USCIITG-LIPS). Mayo Clin Proc; 2014 Feb 02; 89(2):154-62. PubMed ID: 24485129 [Abstract] [Full Text] [Related]
15. [Community-acquired pneumonia in patients with chronic obstructive pulmonary disease treated with inhaled corticosteroids or other bronchodilators. Study PNEUMOCORT]. Morros R, Vedia C, Giner-Soriano M, Casellas A, Amado E, Baena JM, en representación de los investigadores del proyecto PNEUMOCORT. Aten Primaria; 2019 Feb 02; 51(6):333-340. PubMed ID: 29661670 [Abstract] [Full Text] [Related]
16. Influence of inhaled corticosteroids on community-acquired pneumonia in patients with bronchial asthma. To M, To Y, Yamada H, Ogawa C, Otomo M, Suzuki N, Sano Y. Intern Med; 2004 Aug 02; 43(8):674-8. PubMed ID: 15468964 [Abstract] [Full Text] [Related]
18. Influence of steroids on procalcitonin and C-reactive protein in patients with COPD and community-acquired pneumonia. Perren A, Cerutti B, Lepori M, Senn V, Capelli B, Duchini F, Domenighetti G. Infection; 2008 Mar 02; 36(2):163-6. PubMed ID: 18330505 [Abstract] [Full Text] [Related]